Home  >  Products  >  MARC2 (mitochondrial amidoxime reducing component 2 ) Blocking Peptide (the C terminal of MARC2)(100ug)
MARC2 (mitochondrial amidoxime reducing component 2 ) Blocking Peptide (the C terminal of MARC2)(100ug)

MARC2 (mitochondrial amidoxime reducing component 2 ) Blocking Peptide (the C terminal of MARC2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MARC2 Antibody (ARP68677_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP68677
Size: 100ug
Weight: 38kDa
Gene: 54996
Format: Lyophilized powder
Target: As a component of the benzamidoxime prodrug-converting complex, MARC2 is required to reduce N-hydroxylated prodrugs, such as benzamidoxime. It also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine.
Alternative names: MOSC2; RP11-270A6.1
See Full Product Listings >